{"transactions":[{"id":934334,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:05.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018022/ownership.xml","form_type":"4"}},{"id":1296458,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2025-01-23T23:27:39.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001977","document":"form4-01232025_110135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001977/form4-01232025_110135.xml","form_type":"4"}},{"id":1405153,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T20:55:55.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":1487,"price":11.5388,"value":17158.1956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.20 to $11.795. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":154331,"source":{"system":"sec-edgar","filing":"0001415889-24-023588","document":"form4-09182024_120952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924023588/form4-09182024_120952.xml","form_type":"4"}},{"id":1449958,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-23T20:44:20.000Z","date":"2024-07-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares."}],"balance_after":0,"derivative":{"exercise_price":68.01,"expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-020005","document":"form4-07242024_120716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924020005/form4-07242024_120716.xml","form_type":"4"}},{"id":1449957,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-23T20:44:20.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":16250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares."}],"balance_after":155818,"source":{"system":"sec-edgar","filing":"0001415889-24-020005","document":"form4-07242024_120716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924020005/form4-07242024_120716.xml","form_type":"4"}},{"id":1449956,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-23T20:44:20.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":43750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 150,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 43,750 shares and 16,250 shares."}],"balance_after":139568,"source":{"system":"sec-edgar","filing":"0001415889-24-020005","document":"form4-07242024_120716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924020005/form4-07242024_120716.xml","form_type":"4"}},{"id":1475430,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-18T19:44:21.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":1570,"price":7.5753,"value":11893.221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.26 to $7.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":95818,"source":{"system":"sec-edgar","filing":"0001415889-24-017500","document":"form4-06182024_110617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924017500/form4-06182024_110617.xml","form_type":"4"}},{"id":1475429,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-18T19:44:21.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":5.02,"value":15060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":97388,"source":{"system":"sec-edgar","filing":"0001415889-24-017500","document":"form4-06182024_110617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924017500/form4-06182024_110617.xml","form_type":"4"}},{"id":1574831,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-15T19:55:06.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":2535,"price":10.1705,"value":25782.2175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":94388,"source":{"system":"sec-edgar","filing":"0001415889-24-008171","document":"form4-03152024_110357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924008171/form4-03152024_110357.xml","form_type":"4"}},{"id":1574830,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-15T19:55:06.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":2889,"price":9.8752,"value":28529.4528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":96923,"source":{"system":"sec-edgar","filing":"0001415889-24-008171","document":"form4-03152024_110357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924008171/form4-03152024_110357.xml","form_type":"4"}},{"id":1576794,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-14T18:25:11.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option shall vest on April 12, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":92500,"derivative":{"exercise_price":9.95,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0001415889-24-008056","document":"form4-03142024_100305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924008056/form4-03142024_100305.xml","form_type":"4"}},{"id":1576793,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-14T18:25:11.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-sixteenth of the RSUs shall vest on June 12, 2024 and each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":99812,"source":{"system":"sec-edgar","filing":"0001415889-24-008056","document":"form4-03142024_100305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000141588924008056/form4-03142024_100305.xml","form_type":"4"}},{"id":1725545,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-01T19:03:34.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":1180,"price":6.213,"value":7331.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":53562,"source":{"system":"sec-edgar","filing":"0001209191-23-057113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123057113/doc4.xml","form_type":"4"}},{"id":1878202,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:24:46.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":15,"price":13.005,"value":195.075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":54742,"source":{"system":"sec-edgar","filing":"0001209191-23-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123032306/doc4.xml","form_type":"4"}},{"id":1878201,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:24:46.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":1244,"price":12.3005,"value":15301.822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":54757,"source":{"system":"sec-edgar","filing":"0001209191-23-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123032306/doc4.xml","form_type":"4"}},{"id":1878200,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:24:46.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":962,"price":11.71,"value":11265.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":56001,"source":{"system":"sec-edgar","filing":"0001209191-23-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123032306/doc4.xml","form_type":"4"}},{"id":1923819,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-06T21:46:37.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":52500,"derivative":{"exercise_price":12.86,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001209191-23-023703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123023703/doc4.xml","form_type":"4"}},{"id":1923818,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-06T21:46:37.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":55039,"source":{"system":"sec-edgar","filing":"0001209191-23-023703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123023703/doc4.xml","form_type":"4"}},{"id":1950121,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-16T18:31:43.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":1768,"price":18.732,"value":33118.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.34 to $19.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":28789,"source":{"system":"sec-edgar","filing":"0001209191-23-019421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919123019421/doc4.xml","form_type":"4"}},{"id":2079894,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T20:12:16.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":1938,"price":19.3595,"value":37518.711,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":30557,"source":{"system":"sec-edgar","filing":"0001209191-22-062262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122062262/doc4.xml","form_type":"4"}},{"id":2079893,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T20:12:16.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":3492,"price":18.7746,"value":65560.9032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":32495,"source":{"system":"sec-edgar","filing":"0001209191-22-062262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122062262/doc4.xml","form_type":"4"}},{"id":2103434,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-28T20:31:51.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":277,"price":21.9914,"value":6091.6178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":35987,"source":{"system":"sec-edgar","filing":"0001209191-22-058913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122058913/doc4.xml","form_type":"4"}},{"id":2103433,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-28T20:31:51.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":600,"price":21.3765,"value":12825.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":36264,"source":{"system":"sec-edgar","filing":"0001209191-22-058913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122058913/doc4.xml","form_type":"4"}},{"id":2255340,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-26T16:49:04.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":938,"price":17.1039,"value":16043.4582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.79 to $17.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":36864,"source":{"system":"sec-edgar","filing":"0001209191-22-032233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122032233/doc4.xml","form_type":"4"}},{"id":2268269,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-17T19:00:55.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":825,"price":12.38,"value":10213.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":37802,"source":{"system":"sec-edgar","filing":"0001209191-22-029860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122029860/doc4.xml","form_type":"4"}},{"id":2327772,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-17T18:44:36.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":14477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2022, provided that the Reporting Person remains a service provider through the vesting date."}],"balance_after":36977,"source":{"system":"sec-edgar","filing":"0001209191-22-019761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122019761/doc4.xml","form_type":"4"}},{"id":2333414,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-15T20:55:05.000Z","date":"2022-03-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option shall vest on April 12, 2022 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":75000,"derivative":{"exercise_price":17.11,"expiration_date":"2032-03-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-019014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122019014/doc4.xml","form_type":"4"}},{"id":2333413,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:55:05.000Z","date":"2022-03-12","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2023 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001209191-22-019014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919122019014/doc4.xml","form_type":"4"}},{"id":2503013,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-19T20:37:58.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs will vest on each of May 23, 2022, November 22, 2022, May 22, 2023, and November 22, 2023, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-065987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919121065987/doc4.xml","form_type":"4"}},{"id":2617883,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-03T17:42:30.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option shall vest on July 30, 2022, and 1/48 of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person remaining a service provider through each such date."}],"balance_after":150000,"derivative":{"exercise_price":68.01,"expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-049421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919121049421/doc4.xml","form_type":"4"}},{"id":3180782,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":113153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,760,891.75, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,760,891.75, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":113153},"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3180781,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":44710,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $3,878,257.18, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $3,878,257.18, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-26","underlying":"Common Stock","underlying_shares":44710},"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3180780,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":70398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,352,011.54, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,352,011.54, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":5.27,"expiration_date":"2027-11-27","underlying":"Common Stock","underlying_shares":70398},"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3180779,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":4570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $414,121.98, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $414,121.98, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":4570},"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3180778,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":58114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was canceled in the Merger in exchange for a cash payment of $5,432,787.29, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was canceled in the Merger in exchange for a cash payment of $5,432,787.29, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":58114},"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3180777,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-07T12:15:07.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":3906,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-023714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023714/doc4.xml","form_type":"4"}},{"id":3183759,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":2797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on December 13, 2019, subject to Reporting Person's continuous service as of each such date."}],"balance_after":113153,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183758,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":11418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on March 1, 2019, subject to Reporting Person's continuous service as of each such date."}],"balance_after":44710,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-04-26","underlying":"Common Stock","underlying_shares":11418},"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183757,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":7020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on November 8, 2017, subject to Reporting Person's continuous service as of each such date."}],"balance_after":70398,"derivative":{"exercise_price":5.27,"expiration_date":"2027-11-27","underlying":"Common Stock","underlying_shares":7020},"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183756,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on August 15, 2017, subject to Reporting Person's continuous service as of each such date."}],"balance_after":4570,"derivative":{"exercise_price":4.8825,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183755,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":false,"shares":49627,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58114,"derivative":{"exercise_price":2.015,"exercise_date":"2020-02-08","expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":49627},"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183754,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":79195,"price":95.42,"value":7556786.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $95.411 to $95.43, inclusive.  The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3906,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183753,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":2797,"price":35.75,"value":99992.75,"ownership":{"direct":true},"balance_after":83101,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183752,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":11418,"price":8.7575,"value":99993.135,"ownership":{"direct":true},"balance_after":80304,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183751,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":7020,"price":5.27,"value":36995.4,"ownership":{"direct":true},"balance_after":68886,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183750,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":8333,"price":4.8825,"value":40685.8725,"ownership":{"direct":true},"balance_after":61866,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3183749,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-03T17:53:27.000Z","date":"2020-04-01","kind":"exercise","acquired":true,"shares":49627,"price":2.015,"value":99998.405,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,906 shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan."}],"balance_after":53533,"source":{"system":"sec-edgar","filing":"0001209191-20-023395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919120023395/doc4.xml","form_type":"4"}},{"id":3339212,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-17T19:28:06.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":115950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments beginning with the vesting commencement date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":115950,"derivative":{"exercise_price":35.75,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":115950},"source":{"system":"sec-edgar","filing":"0001209191-19-061042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119061042/doc4.xml","form_type":"4"}},{"id":3345422,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-11T21:57:59.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":107741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-060143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119060143/doc4.xml","form_type":"4"}},{"id":3345421,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-11T21:57:59.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-060143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119060143/doc4.xml","form_type":"4"}},{"id":3345420,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-11T21:57:59.000Z","date":"2019-12-10","kind":"exercise","acquired":true,"shares":10000,"price":2.015,"value":20150.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-060143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119060143/doc4.xml","form_type":"4"}},{"id":3346738,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-10T21:53:43.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":117741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-059961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119059961/doc4.xml","form_type":"4"}},{"id":3346737,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-10T21:53:43.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":10000,"price":30,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-059961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119059961/doc4.xml","form_type":"4"}},{"id":3346736,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-10T21:53:43.000Z","date":"2019-12-09","kind":"exercise","acquired":true,"shares":10000,"price":2.015,"value":20150.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-059961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119059961/doc4.xml","form_type":"4"}},{"id":3432283,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-21T11:37:44.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":663,"price":6.3586,"value":4215.7518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan on August 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.47, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-046934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119046934/doc4.xml","form_type":"4"}},{"id":3536581,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-07T19:33:13.000Z","date":"2019-05-03","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":127741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-028110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119028110/doc4.xml","form_type":"4"}},{"id":3536580,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-07T19:33:13.000Z","date":"2019-05-03","kind":"sale","acquired":false,"shares":8000,"price":17.9939,"value":143951.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.62 to $18.33, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-028110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119028110/doc4.xml","form_type":"4"}},{"id":3536579,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-07T19:33:13.000Z","date":"2019-05-03","kind":"exercise","acquired":true,"shares":8000,"price":2.015,"value":16120.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-028110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119028110/doc4.xml","form_type":"4"}},{"id":3560448,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-08T19:20:33.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":135741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-024045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119024045/doc4.xml","form_type":"4"}},{"id":3560447,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-08T19:20:33.000Z","date":"2019-04-04","kind":"sale","acquired":false,"shares":8000,"price":16.3881,"value":131104.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.09 to $16.70, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-024045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119024045/doc4.xml","form_type":"4"}},{"id":3560446,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-08T19:20:33.000Z","date":"2019-04-04","kind":"exercise","acquired":true,"shares":8000,"price":2.015,"value":16120.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-024045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119024045/doc4.xml","form_type":"4"}},{"id":3608652,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-06T20:55:01.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":143741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-017588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119017588/doc4.xml","form_type":"4"}},{"id":3608651,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-06T20:55:01.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":8000,"price":16.9438,"value":135550.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.30, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-017588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119017588/doc4.xml","form_type":"4"}},{"id":3608650,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-06T20:55:01.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":8000,"price":2.015,"value":16120.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-017588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119017588/doc4.xml","form_type":"4"}},{"id":3642125,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-21T19:45:56.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":2500,"price":15.0485,"value":37621.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan on February 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.91 to $15.55, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-012322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119012322/doc4.xml","form_type":"4"}},{"id":3674593,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T19:02:36.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":151741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-007526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119007526/doc4.xml","form_type":"4"}},{"id":3674592,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-05T19:02:36.000Z","date":"2019-02-04","kind":"sale","acquired":false,"shares":8000,"price":14.8592,"value":118873.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.49 to $15.15, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-007526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119007526/doc4.xml","form_type":"4"}},{"id":3674591,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-05T19:02:36.000Z","date":"2019-02-04","kind":"exercise","acquired":true,"shares":8000,"price":2.015,"value":16120.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-007526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119007526/doc4.xml","form_type":"4"}},{"id":3700501,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-08T20:17:42.000Z","date":"2019-01-04","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option vested one year after February 8, 2016 and 1/48th of the shares subject to the option vest monthly thereafter, subject to Reporting Person's continuous service as of each such date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase."}],"balance_after":159741,"derivative":{"exercise_price":2.015,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-002922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119002922/doc4.xml","form_type":"4"}},{"id":3700500,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-08T20:17:42.000Z","date":"2019-01-04","kind":"sale","acquired":false,"shares":8000,"price":15.5453,"value":124362.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.10 to $16.02, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-002922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119002922/doc4.xml","form_type":"4"}},{"id":3700499,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-08T20:17:42.000Z","date":"2019-01-04","kind":"exercise","acquired":true,"shares":8000,"price":2.015,"value":16120.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-002922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743780/000120919119002922/doc4.xml","form_type":"4"}}]}